NDTVCenter·
GLP-1 Debate: Kiran Mazumdar-Shaw Warns Of Long-Term Risks As Nithin Kamath Flags Weak Demand
Biocon's executive chairperson says lifestyle changes should remain the first choice, while Zerodha's founder says generic GLP-1 uptake has lagged despite lower prices.
Read at NDTV →



